CompletedNot applicableNCT02899754

Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions

Veterans have a high risk of developing lung in comparison to general populations due to their older age and smoking history. Recent evidence indicates that lung cancer screening with low dose CT scan reduces lung cancer mortality among older heavy smokers. However, the rates of false positive findings are high, requiring further testing and evaluation. The aims of this study were to 1) elicit patient and provider stakeholder input to inform the development of a lung cancer screening decision tool, 2) develop a web-based Lung Cancer Screening Decision Tool (LCSDecTool) that incorporates patient and provider input, and 3) conduct a RCT to evaluate LCSDecTool compared to usual care knowledge about LCS, decisional conflict and uptake of LCS. The investigators hypothesized that the use of the LCSDecTool would decrease decisional conflict at 1 month. As a secondary outcome the investigators hypothesized that there would be a decrease in uptake of LCS in the LCDDecTool group compared with the control intervention due to increased awareness of harms associated with LCS. Additional secondary outcomes were LCS knowledge, decisional regret, anxiety, and lung cancer worry. Veterans who were receiving primary care in a participating VA Medical Center, aged 55 to 80 years with a smoking history of at least 30 pack-years who were current smokers or had quit within the past 15 years were eligible to participate in the study. Participants were asked to link on to a study website and were randomly assigned to the LCSDecTool or a control intervention website. Following use of the intervention, participants had a primary care visit. Patient reported outcomes were assessed immediately post intervention and at 1 and 3-months post intervention. LCS uptake was assessed at 6 months post-intervention.

Checked against the public recordLast updated Nov 14, 2024 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations3
SponsorVA Office of Research and Development
01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
VA Office of Research and Development
Interventions being studied
Behavioral: Lung Cancer Screening Decision Tool; Behavioral: Control Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Age 55-80 years * Enrolled in a Patient Aligned Care Team at a participating site * 30 or more pack years of smoking * Active smoker or quit smoking within 15 years Exclusion Criteria: * Cognitive impairment as determined by clinical history * Previous diagnosis of cancer with the exception of non-melanoma skin cancer and localized prostate cancer that is 1-year post-diagnosis * Life expectancy of less than 2 years as indicated by chart review and conformation with PCPC * Inability to speak English * Active surveillance of Lung Nodule, * Enrolled in CMCVAMC Lung Cancer Screening Program

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CTWest Haven, Connecticut
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PAPhiladelphia, Pennsylvania
  • Clement J. Zablocki VA Medical Center, Milwaukee, WIMilwaukee, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 14, 2024. Always confirm current availability with the study team.

View original record ↗